Potential Risks to Fetal Development Animal studies offer potential risks to fetal development, such as: Decreased weight at birth Harm to fetal development Birth defects to internal organs Birth defects involving the musculoskeletal structure Minor differences in bone structure Higher chance of miscarriage GLP-1s and Breastfeeding: What We Know (And Don't Know) Similar to pregnancy, few studies explore whether GLP-1 medications are safe when breastfeeding
P.GalliA.et al
Bacteriostatic water contains a preservative that inhibits microbial growth, extending the usable life of your reconstituted solution to 2-4 weeks when refrigerated
McDonald suspects that GLP-1 medicines, as they regulate hunger and digestion hormones, also trigger other metabolic pathways
JAMA Netw Open 7(1):e2350408e2350408 [DOI] [PMC free article] [PubMed] [Google Scholar] Deacon CF (2019) Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes
Overall, the benefit-risk profile supports broad use of GLP-1-based therapies in MASLD across most patient subgroups, with individualized monitoring plans for high-risk populations